Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3251538
Max Phase: Preclinical
Molecular Formula: C16H15N5
Molecular Weight: 277.33
Molecule Type: Small molecule
Associated Items:
ID: ALA3251538
Max Phase: Preclinical
Molecular Formula: C16H15N5
Molecular Weight: 277.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N=C(N)c1ccc(-c2cc3ccc(C(=N)N)cn3c2)cc1
Standard InChI: InChI=1S/C16H15N5/c17-15(18)11-3-1-10(2-4-11)13-7-14-6-5-12(16(19)20)8-21(14)9-13/h1-9H,(H3,17,18)(H3,19,20)
Standard InChI Key: CPOSARSRRJROGR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 277.33 | Molecular Weight (Monoisotopic): 277.1327 | AlogP: 2.17 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.15 | Molecular Species: BASE | HBA: 3 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 11.51 | CX LogP: 1.10 | CX LogD: -3.69 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.44 | Np Likeness Score: -0.37 |
1. Tidwell RR, Geratz JD, Dann O, Volz G, Zeh D, Loewe H.. (1978) Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases., 21 (7): [PMID:671460] [10.1021/jm00205a005] |
Source(1):